Skip to main content
. 2022 Mar 29;12(4):302. doi: 10.3390/metabo12040302

Figure 1.

Figure 1

Clinical (panels AD), demographic (panel E), and anthropometric (panels FI) characteristics of study participants (n = 50). (A) Lactulose/rhamnose ratio (LRR), (B) lipopolysaccharide binding protein (LBP) levels, (C) C-reactive protein (CRP) levels, (D) irritable bowel syndrome severity scoring system (IBS-SSS), (E) age, (F) body mass index (BMI), (G) weight, (H) height, and (I) waist circumference of healthy and increased intestinal permeability (IP) study participants. **** p < 0.0001.